FundedIQ
Biotechnology

Watchmaker Genomics: Funding, Investors & Team (Aug 2026)

Watchmaker Genomics is a biotechnology organization that spotlights on leading edge applications for perusing, composing, and altering DNA. It joins profound space skill in protein designing with catalyst assembling to address the requesting quality, execution, and scale prerequisites of high-development genomics applications, empowering clients to work on their trial, examine, and work process with versatile production network arrangements that give sub-atomic grade chemicals to a scope of genomic applications.

watchmakergenomics.com LinkedIn Boulder, United States 51-100 employees
Total raised
$40.0M
Rounds
1
Latest
Series A
Jun 2022

Watchmaker Genomics has raised $40.0M across 1 funding round on record, the most recent a Series A of $40.0M announced in Jun 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Watchmaker Genomics Company Profile and Key Stats

Total funding raised
$40.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$40.0M in Jun 2022
Employees
51-100
reported band
Headquarters
Boulder, United States

Latest funding round on record: Jun 2022.

Watchmaker Genomics Funding Rounds

Date
Round
Amount
Series A
$40.0M

Watchmaker Genomics Founders and Leadership Team

Name
Role
Contact
Brian Kudlow
Founder
Locked

Contact details for the Watchmaker Genomics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Watchmaker Genomics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
8,352
$15M

Watchmaker Genomics' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Watchmaker Genomics in Biotechnology and Boulder

Companies Similar to Watchmaker Genomics

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Watchmaker Genomics Funding FAQs

What does Watchmaker Genomics do?

Watchmaker Genomics is a biotechnology organization that spotlights on leading edge applications for perusing, composing, and altering DNA. It joins profound space skill in protein designing with catalyst assembling to address the requesting quality, execution, and scale prerequisites of high-development genomics applications, empowering clients to work on their trial, examine, and work process with versatile production network arrangements that give sub-atomic grade chemicals to a scope of genomic applications.

How much funding has Watchmaker Genomics raised?

Watchmaker Genomics has raised $40.0M across 1 round on record. The most recent is a Series A of $40.0M announced in Jun 2022.

When did Watchmaker Genomics last raise funding?

Watchmaker Genomics' most recent funding round on record is a Series A of $40.0M, announced in Jun 2022.

Who founded Watchmaker Genomics?

FundedIQ lists Brian Kudlow (Founder) at Watchmaker Genomics.

Where is Watchmaker Genomics headquartered?

Watchmaker Genomics is based in Boulder, Colorado, United States.

How many employees does Watchmaker Genomics have?

Watchmaker Genomics is in the 51-100 employee band.

How does Watchmaker Genomics' funding compare to other Biotechnology startups?

Watchmaker Genomics' latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Watchmaker Genomics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Watchmaker Genomics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.